IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India

Molecular and Cellular Biochemistry

Volumn 385, Issue 1-2, 2014, Pages 297-307

  Saxena, Roli ^a   Chawla, Yogesh Kumar ^a   Verma, Indu ^a   Kaur, Jyotdeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

HBV; HCC; IFN ; TNF

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B VIRUS; HUMAN; INDIA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CARCINOGENESIS; VIRUS CARRIER; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B VIRUS; HETEROZYGOTE; HUMANS; INDIA; INTERFERON-GAMMA; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890539572     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1838-9     Document Type: Article

References (56)

1. Wang B, Wang J, Zheng Y, Zhou S, Zheng J, Wang F, Ma X, Zeng Z (2010) A study of TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology 42:674-680. doi: 10.3109/00313025.2010.523696
2. Saxena R, Chawla YK, Verma I, Kaur J (2012) Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India. J Interferon Cytokine Res. doi: 10.1089/jir.2012.0093
3. Sun QL, Ran W (2004) Review of cytokine profiles in patients with hepatitis. World J Gastroenterol 10:1709-1715
4. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C (1998) A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111:579-582
5. Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH (2008) Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis 14:1815-1818
6. Kumar A, Gupta V, Changotra H, Sarin BC, Sehajpal PK (2008) Tumor necrosis factor-alpha and transforming growth factor-beta1 polymorphisms in bronchial asthma. Indian J Med Sci 62:323-330
7. Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, Soto L, Cruzat A, Salazar-Onfray F, Aguillon JC (2003) The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 42:308-313
8. Costeas PA, Koumas L, Koumouli A, Kyriakou-Giantsiou A, Papaloizou A (2003) Cytokine polymorphism frequencies in the Greek Cypriot population. Eur J Immunogenet 30:341-343
9. Grove J, Daly AK, Bassendine MF, Day CP (1997) Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26:143-146. doi: 10.1002/hep.510260119
10. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T (2003) Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144-150. doi: 10.1111/j.1572-0241.2003.07179.x
11. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Govindarajan S, Yu MC (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103:740-748. doi: 10.1002/cncr.20842
12. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, Stuver SO, Ido A, Tsubouchi H (2006) Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34:24-31. doi: 10.1016/j.cyto.2006.03.011
13. Zhang W, Yue B, Wang GQ, Lu SL (2002) Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 1:577-580. doi: 527 [pii]
14. Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B (2006) The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006:78380. doi: 10.1155/MI/2006/78380
15. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863-866
16. Bendicho MT, Guedes JC, Silva NN, Santana GO, dos Santos RR, Lyra AC, Lyra LG, Meyer R, Lemaire DC (2005) Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis. Pancreas 30:333-336
17. Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L (2008) Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35:197-205. doi: 10.1111/j.1744-313X.2008.00752.x
18. Vidyarani M, Selvaraj P, Prabhu Anand S, Jawahar MS, Adhilakshmi AR, Narayanan PR (2006) Interferon gamma (IFNgamma) & interleukin-4 (IL-4) gene variants & cytokine levels in pulmonary tuberculosis. Indian J Med Res 124:403-410
19. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560-567
20. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, Conti P, Vecchiet J (2006) Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 36:144-150
21. Zhou L, Liu J, Luo F (2006) Serum tumor markers for detection of hepatocellular carcinoma. Methods Enzymol 12:1175-1181
22. Daly AK, Steen VM, Fairbrother KS, Idle JR (1996) CYP2D6 multiallelism. Methods Enzymol 272:199-210
23. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, Chiou HL (2007) Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res 150:116-121. doi: 10.1016/j.trsl.2007.01.007
24. Boyum A (1968) Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 97:9-29
25. Towbin H, Staehelin T, Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24:145-149
26. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829
27. Vikram NK, Bhatt SP, Bhushan B, Luthra K, Misra A, Poddar PK, Pandey RM, Guleria R (2011) Associations of -308G/A polymorphism of tumor necrosis factor (TNF)-alpha gene and serum TNF-alpha levels with measures of obesity, intra-abdominal and subcutaneous abdominal fat, subclinical inflammation and insulin resistance in Asian Indians in north India. Dis Markers 31:39-46. doi: 10.3233/DMA-2011-0802
28. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K (2005) Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection - association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 42:505-510. doi: 10.1016/j.jhep.2004.11.026
29. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK (2007) Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens 69:113-120. doi: 10.1111/j.1399-0039.2006.00740.x
30. Sharma S, Ghosh B, Sharma SK (2008) Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 151:251-259. doi: 10.1111/j.1365-2249.2007. 03564.x
31. Somi MH, Najafi L, Noori BN, Alizadeh AH, Aghah MR, Shavakhi A, Ehsani MJ, Aghazadeh R, Masoodi M, Amini S, Baladast M, Zali MR (2006) Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol 25:14-15
32. Zein NN, Germer JJ, El-Zayadi AR, Vidigal PG (2004) Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg 70:434-437
33. Trajkov D, Arsov T, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Spiroski M (2005) Cytokine gene polymorphisms in population of ethnic Macedonians. Croat Med J 46:685-692
34. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, Daikoku M, Yatsuhashi H, Koga M, Yano M, Eguchi K (2002) Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 97:2086-2092. doi: 10.1111/j.1572-0241.2002.05926.x
35. Chan HL, Tse AM, Chim AM, Wong VW, Choi PC, Yu J, Zhang M, Sung JJ (2008) Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B. J Gastroenterol Hepatol 23:783-789. doi: 10.1111/j.1440-1746.2007. 05110.x
36. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG (2007) Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 9:987-992
37. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M (2007) TNF alpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29:249-256
38. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M (2009) Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114:347-355. doi: 10.1007/s10549-008-0006-5
39. Budak F, Goral G, Heper Y, Yilmaz E, Aymak F, Basturk B, Tore O, Ener B, Oral HB (2007) IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 38:32-36. doi: 10.1016/j.cyto.2007.04.008
40. Yilmaz V, Demirbilek V, Gurses C, Yentur SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gokyigit A, Saruhan-Direskeneli G (2007) Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13:410-415. doi: 10.1080/ 13550280701455383
41. Colakogullari M, Ulukaya E, Yilmaztepe Oral A, Aymak F, Basturk B, Ursavas A, Oral HB (2008) The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26:283-290. doi: 10.1002/cbf.1419
42. Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH (2006) Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet 44:246-255. doi: 10.1007/s10528-006-9029-y
43. Kamali-Sarvestani E, Merat A, Talei AR (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223:113-119. doi: 10.1016/j.canlet.2004.09.025
44. Wu WS, McClain KL (1997) DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 17:631-635
45. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
46. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399
47. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 215:75-78
48. Lichtenstein M, Zimran A, Horowitz M (1997) Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 23:395-401. doi: 10.1006/bcmd.1997.0156
49. Kothari ST, Deshmukh RA (2006) Estimation of mRNA levels of Interleukin (IL)-10, Tumor Necrosis Factor (TNF)-α, IL-4 and Interferon (IFN)-γ in HIV infected children in Mumbai. Indian J Clin Biochem 21:15-26
50. Fan XG, Liu WE, Li CZ, Wang ZC, Luo LX, Tan DM, Hu GL, Zhang Z (1998) Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm 7:295-297. doi: 10.1080/09629359890992
51. le Song H, Binh VQ, Duy DN, Kun JF, Bock TC, Kremsner PG, Luty AJ (2003) Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28:93-103
52. Gramenzi A, Andreone P, Loggi E, Foschi FG, Cursaro C, Margotti M, Biselli M, Bernardi M (2005) Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepat 12:525-530. doi: 10.1111/j.1365-2893.2005.00634.x
53. Ayada M, Ishikawa T, Okumura A, Tanabe J, Ito H, Ohashi T, Matsumoto E, Sato K, Hotta N, Fukuzawa Y, Kakumu S (2006) Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection. Hepatol Res 34:214-221. doi: 10.1016/j.hepres.2006.01.001
54. Forte GI, Scola L, Misiano G, Milano S, Mansueto P, Vitale G, Bellanca F, Sanacore M, Vaccarino L, Rini GB, Caruso C, Cillari E, Lio D, Mansueto S (2009) Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever. Clin Vaccine Immunol 16:811-815. doi: 10.1128/CVI.00121-09
55. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M (2004) Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6:297-305. doi: 10.1016/j.ccr.2004.08.012
56. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183. doi: 10.1172/JCI31537